personal scheduler Hamburg 2013 - Main Site Press Release 2013 Call for Abstracts General Information Programme Overview Letter from the President Keynote Lectures Main Sessions NEW - Free Paper Session Instructional Courses World Retina Day Retinal Detachment Course Uveitis Course Other Symposia Surgical Skills Training Courses
hamburg banner

BOON- an interactive database for management of intravitreal injections in clinical practice

Session Details

Session Title: New drug treatment and technology

Session Date/Time: Friday 27/09/2013 | 14:30-16:00

Paper Time: 14:54

Venue: Hall 3 (Level 0)

First Author: N.Eter GERMANY

Co Author(s):    C. Milojcic   R. Fimmers   P. Sarbach   C. Clemens     

Abstract Details

Purpose:

Monthly follow-up is necessary to preserve initial gain in visual acuity in patients having received anti-VEGF therapy for wet age-related macular degeneration (AMD), diabetic macular edema (DME), and macular edema (ME) in retinal vein occlusion (RVO),. Observational studies, however, show that those monthly visits are not performed for logistical reasons. Therefore, the aim of the present study was to establish a common database between treating and referring physicians to enable a tighter patient care.

Setting:

Non-randomized IT-based observational study.

Methods:

In a German pilot project with participation of one ophthalmology department and 10 referring ophthalmic practices an online database for electronic data files was created to optimize patients’ care after intravitreal injections. Real life monitoring data such as best-corrected visual acuity, retinal thickness and morphological criteria were entered by both, the treating department and the referring physician in chronological sequence. Automated alert emails were generated in the following situations: interval between visits was longer than 5 weeks, diagnosed vision loss was greater than 5 letters, or retinal thickness, measured by OCT, increased more than 100 µm.

Results:

Out of 96 patients included in the database, 93 patients had a follow-up of at least 12 months. The most frequent pathology was exudative AMD, representing more than 85% of treated patients. Mean best-corrected visual acuity increased slightly from 0,251at baseline to 0.34 after 1 year. Mean number of injections given in the first year was 3.7.

Conclusions:

Using a shared electronic patient file can help to improve monitoring of patients after intravitreal injection, and improve cooperation between treating and referring ophthalmologists. Nevertheless, adhering to a PRN scheme is challenging for both, patients and physicians.

Back to Freepaper Session
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy